Johns Hopkins ABX Guide
Norfloxacin
Norfloxacin is a topic covered in the Johns Hopkins ABX Guide.
To view the entire topic, please sign in or purchase a subscription.
Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
FDA
- Uncomplicated endocervical and urethral gonorrhea (no longer recommended)
- Prostatitisdue to E. coli
- Uncomplicated urinary tract infections (including cystitis)
- Due to Enterococcus faecalis, Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa, Staphylococcus epidermidis, Staphylococcus saprophyticus, Citrobacter freundii, Enterobacter aerogenes, Enterobacter cloacae, Proteus vulgaris, Staphylococcus aureus, or Streptococcus agalactiae.
- Complicated urinary tract infections
- Due to Enterococcus faecalis, Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa, or Serratia marcescens.
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Spontaneous bacterial peritonitis prophylaxis
- Antibiotic prophylaxis in afebrile neutropenic patients with hematological malignancies
-- To view the remaining sections of this topic, please sign in or purchase a subscription --
INDICATIONS
FDA
FDA
- Uncomplicated endocervical and urethral gonorrhea (no longer recommended)
- Prostatitisdue to E. coli
- Uncomplicated urinary tract infections (including cystitis)
- Due to Enterococcus faecalis, Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa, Staphylococcus epidermidis, Staphylococcus saprophyticus, Citrobacter freundii, Enterobacter aerogenes, Enterobacter cloacae, Proteus vulgaris, Staphylococcus aureus, or Streptococcus agalactiae.
- Complicated urinary tract infections
- Due to Enterococcus faecalis, Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa, or Serratia marcescens.
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Spontaneous bacterial peritonitis prophylaxis
- Antibiotic prophylaxis in afebrile neutropenic patients with hematological malignancies
There's more to see -- the rest of this entry is available only to subscribers.
Last updated: February 1, 2016
Citation
Pham, Paul A, and John G Bartlett. "Norfloxacin." Johns Hopkins ABX Guide, The Johns Hopkins University, 2016. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540391/all/Norfloxacin.
Pham PA, Bartlett JG. Norfloxacin. Johns Hopkins ABX Guide. The Johns Hopkins University; 2016. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540391/all/Norfloxacin. Accessed January 20, 2020.
Pham, P. A., & Bartlett, J. G. (2016). Norfloxacin. In Johns Hopkins ABX Guide. Available from https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540391/all/Norfloxacin
Pham PA, Bartlett JG. Norfloxacin [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2016. [cited 2020 January 20]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540391/all/Norfloxacin.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Norfloxacin
ID - 540391
A1 - Pham,Paul,Pharm.D.
AU - Bartlett,John,M.D.
Y1 - 2016/02/01/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540391/all/Norfloxacin
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine
ER -